RISPERIDON ACTAVIS 2MG õhukese polümeerikattega tablett Estonia - estoński - Ravimiamet

risperidon actavis 2mg õhukese polümeerikattega tablett

teva b.v. - risperidoon - õhukese polümeerikattega tablett - 2mg 60tk; 2mg 20tk

OMEPRAZOLE GRINDEKS gastroresistentne kõvakapsel Estonia - estoński - Ravimiamet

omeprazole grindeks gastroresistentne kõvakapsel

grindeks as - omeprasool - gastroresistentne kõvakapsel - 20mg 500tk; 20mg 28tk; 20mg 60tk; 20mg 7tk; 20mg 56tk; 20mg 30tk; 20mg 14tk

GASEC GASTROCAPS 40 MG gastroresistentne kõvakapsel Estonia - estoński - Ravimiamet

gasec gastrocaps 40 mg gastroresistentne kõvakapsel

teva b.v. - omeprasool - gastroresistentne kõvakapsel - 40mg 14tk

RISPERIDON ACTAVIS 4MG õhukese polümeerikattega tablett Estonia - estoński - Ravimiamet

risperidon actavis 4mg õhukese polümeerikattega tablett

teva b.v. - risperidoon - õhukese polümeerikattega tablett - 4mg 60tk

Segluromet Unia Europejska - estoński - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Invokana Unia Europejska - estoński - EMA (European Medicines Agency)

invokana

janssen-cilag international nv - canagliflozin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ja 5.

RISPERIDONE GRINDEKS õhukese polümeerikattega tablett Estonia - estoński - Ravimiamet

risperidone grindeks õhukese polümeerikattega tablett

grindeks as - risperidoon - õhukese polümeerikattega tablett - 2mg 30tk; 2mg 20tk

Zontivity Unia Europejska - estoński - EMA (European Medicines Agency)

zontivity

merck sharp dohme limited - vorapaksaarsulfaat - müokardi infarkt - antitrombootilised ained - zontivityis märgitud vähendamise atherothrombotic sündmuste täiskasvanud patsientidel, kellel on - on esinenud müokardiinfarkt (mi)co-manustada atsetüülsalitsüülhape (asa) ja vajaduse korral clopidogrel; või - sümptomaatiline perifeersete arterite haigus(pad), co-manustada atsetüülsalitsüülhape (asa) või vajaduse korral clopidogrel.

RISPOLEPT 1 mg õhukese polümeerikattega tablett Estonia - estoński - Ravimiamet

rispolept 1 mg õhukese polümeerikattega tablett

johnson & johnson uab - risperidoon - õhukese polümeerikattega tablett - 1mg 100tk; 1mg 20tk; 1mg 60tk; 1mg 500tk; 1mg 50tk; 1mg 6tk

MEDORISPER õhukese polümeerikattega tablett Estonia - estoński - Ravimiamet

medorisper õhukese polümeerikattega tablett

medochemie limited - risperidoon - õhukese polümeerikattega tablett - 1mg 30tk; 1mg 10tk; 1mg 90tk; 1mg 120tk; 1mg 100tk